Is a complete INO research report available?

No complete published report is available for Inovio Pharmaceuticals, Inc. (INO) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Inovio Pharmaceuticals, Inc. (INO)

NASDAQ: INO · USD

$0.97

-0.05 (-4.9%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first INO analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	79.8M
Net income (ttm)	-84.9M
EPS (ttm)	-$1.56
Shares out	82.3M
Volume	3,719,690
Beta	1.48
Price target	$3.43	+253.6%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -84.9M
EPS (ttm): -$1.56
Market cap: 79.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All INO indicators

Market & fundamental data

Available fields

201

Groups with data

Currency

USD

Showing 201 of 201 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001055726
Company name	Inovio Pharmaceuticals, Inc.
Country	United States
Country code	US
Cusip	45773H409
Employees	112
Employees Change	-22%
Employees Change Percent	-16.42
Enterprise value	$50.8M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	1998-02-12
Isin	US45773H4092
Last refreshed	2026-07-25
Market cap	$79.8M
Market cap category	Micro-Cap
Price	$0.97
Price currency	USD
Sector	Healthcare
Sector PE	44.87
Sector PE Fwd	23.76
Sic	2834
Symbol	INO
Website	https://www.inovio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-106.42%
EV Sales Forward	6.73x
FCF yield	-104.71%
P/B ratio	11.16x
PS Forward	10.56x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-52.2M
Net Income	$-84.9M
Net Income Growth Quarters	2%
Net Income Growth Years	4%
Profit Per Employee	$-758,339
ROA	-76.36
Roa5y	-42.34
ROCE	-706.3
ROE	-296.4
Roe5y	-107.8
ROIC	-135.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-37.67%
Cagr15y	-20.89%
Cagr1y	-37.83%
Cagr20y	-20.68%
Cagr3y	-46.23%
Cagr5y	-60.31%
EPS Growth Quarters	15
EPS Growth Years	4
Revenue Growth	-69.99x
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$49.8M
Cash	$37.7M
Current Assets	$39.4M
Current Liabilities	$37.9M
Debt	$8.7M
Debt Equity	$1.43
Equity	$6.1M
Liabilities	$43.7M
Long Term Assets	$10.3M
Long Term Liabilities	$5.8M
Net Cash	$29M
Net Cash By Market Cap	$36.32
Net Cash Growth	-49.23%
Net Debt Equity	$-4.78
Tangible Book Value	$6.1M
Tangible Book Value Per Share	$0.09
WACC	11.2

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.04
Net Working Capital	$-33.3M
Quick ratio	0.99
Working Capital	$1.5M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-75.88%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.11%
1Y total return	-37.81%
200-day SMA	1.62
3Y total return	-84.46%
50-day SMA	1.17
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.01%
All Time High	2,352
All Time High Change	-99.96%
All Time High Date	2000-03-06
All Time Low	0.96
All Time Low Change	1.04%
All Time Low Date	2026-07-24
ATR	0.06
Beta	1.48
Beta1y	1.5
Beta2y	1.5
Ch YTD	-44.25
High	1.04
High52	2.98
High52 Date	2025-09-09
High52ch	-67.44%
Low	0.96
Low52	0.96
Low52 Date	2026-07-24
Low52ch	1.04%
Ma50ch	-16.8%
Premarket Change Percent	0.98
Premarket Price	$1.03
Premarket Volume	1,279
Price vs 200-day SMA	-40.23%
RSI	28.69
RSI Monthly	35.45
RSI Weekly	36.02
Sharpe ratio	-0.24x
Sortino ratio	-0.25
Total Return	-75.88%
Tr YTD	-44.25
Tr15y	-97.03%
Tr1m	-14.15%
Tr1w	-13.38%
Tr3m	-14.9%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	1
Analyst Price Target Top	$2.5
Analyst Ratings	Hold
Analyst Ratings Top	Hold
Earnings EPS Estimate	$-0.28
Earnings Revenue Estimate	400,000x
Operating Income	$-83.7M
Price target	$3.43
Price Target Change	$254
Price Target Change Top	$158

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	81,883,103%
Float Percent	99.53%
Shares Insiders	0.47%
Shares Institutions	38.15%
Shares Out	82,273,237
Shares Qo Q	11.4%
Shares Yo Y	75.88%
Short Float	18.37%
Short Ratio	10.16
Short Shares	18.28

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-86.6M
Average Volume	1,560,538.85x
Bv Per Share	0.09
CAPEX	$-226,325
Ch10y	-99.11
Ch15y	-97.03
Ch1m	-14.15
Ch1w	-13.38
Ch1y	-37.81
Ch20y	-99.03
Ch3m	-14.9
Ch3y	-84.46
Ch5y	-99.01
Ch6m	-35.75
Change	-4.89%
Change From Open	-5.82
Close	1.02
Days Gap	0.98
Depreciation Amortization	1,363,390
Dollar Volume	3,608,471.3
Earnings Date	2026-08-11
Earnings Time	amc
EBIT	$-83.7M
EBITDA	$-80.7M
EPS	$-1.56
F Score	1
FCF	$-83.6M
FCF EV Yield	-164.43x
FCF Per Share	$-1.02
Financing CF	52,975,955
Fiscal Year End	December
Founded	1,979
Investing CF	16,726,967
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-13
Last Report Date	2026-03-31
Last Split Date	2024-01-25
Last Split Type	Reverse
Last10k Filing Date	2026-03-12
Ma150	1.43
Ma150ch	-32.26%
Ma20	1.13
Ma20ch	-14.38%
Net CF	-13,643,797
Next Earnings Date	2026-08-11
Open	1.03
Optionable	Yes
Position In Range	12.52
Post Close	0.97
Postmarket Change Percent	3.01
Postmarket Price	$1
Ppne	8,325,062
Pre Close	1.02
Price Date	2026-07-24
Ptbv Ratio	13.15
Relative Volume	2.38x
Share Based Comp	3,055,183
Tr20y	-99.03%
Tr6m	-35.75%
Us State	Pennsylvania
Volume	3,719,690
Z Score	-55.69

Inovio Pharmaceuticals, Inc. (INO)

Coverage state: Market snapshot only — no published research

Generate the first INO analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · INO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All INO indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on INO

Frequently asked questions